Qube Research & Technologies LTD Vir Biotechnology, Inc. Transaction History

Qube Research & Technologies LTD

  • $93.8 Billion
  • Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 440,005 shares of VIR stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
440,005
Previous 290,676 51.37%
Holding current value
$2.31 Million
Previous $1.88 Million 17.74%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$4.5 - $6.48 $671,980 - $967,651
149,329 Added 51.37%
440,005 $2.22 Million
Q1 2025

May 15, 2025
BUY
$6.48 - $12.48 $879,770 - $1.69 Million
135,767 Added 87.64%
290,676 $1.88 Million
Q4 2024

Feb 14, 2025
SELL
$6.74 - $10.17 $1.37 Million - $2.07 Million
-203,177 Reduced 56.74%
154,909 $1.14 Million
Q3 2024

Nov 14, 2024
BUY
$7.26 - $10.7 $2.41 Million - $3.56 Million
332,421 Added 1295.23%
358,086 $2.68 Million
Q2 2024

Aug 14, 2024
SELL
$7.63 - $12.66 $1.23 Million - $2.04 Million
-161,178 Reduced 86.26%
25,665 $228,000
Q1 2024

May 14, 2024
SELL
$8.6 - $11.9 $271,295 - $375,397
-31,546 Reduced 14.44%
186,843 $1.89 Million
Q4 2023

Feb 13, 2024
BUY
$7.76 - $10.29 $1.38 Million - $1.83 Million
178,141 Added 442.61%
218,389 $2.2 Million
Q3 2023

Nov 13, 2023
BUY
$9.14 - $24.62 $52,893 - $142,475
5,787 Added 16.79%
40,248 $377,000
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $799,495 - $940,440
34,461 New
34,461 $845,000
Q2 2022

Aug 15, 2022
SELL
$19.08 - $26.7 $6.28 Million - $8.78 Million
-328,914 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$21.19 - $40.01 $6.97 Million - $13.2 Million
328,914 New
328,914 $8.46 Million
Q2 2020

Aug 14, 2020
SELL
$27.89 - $47.86 $721,430 - $1.24 Million
-25,867 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$12.04 - $60.2 $311,438 - $1.56 Million
25,867 New
25,867 $886,000

Others Institutions Holding VIR

# of Institutions
245
Shares Held
109M
Call Options Held
350K
Put Options Held
150K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $696M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email